Skip to main content

Coagulopathy Assessment in Patients with COVID-19: A TriNetX Analysis

Basic Details
Date
Type
Presentation
Description

This presentation was given at the Reagan-Udall Foundation and Friends of Cancer Research COVID-19 Diagnostics Evidence Accelerator Parallel Analysis meeting by Mayura Shinde from Harvard Pilgrim Health Care Institute on behalf of the FDA Sentinel COVID-19 Coagulopathy workgroup.

Materials

Coagulopathy Assessment in Patients with COVID-19: A TriNetX Analysis

Information
Host

Reagan-Udall Foundation and Friends of Cancer Research COVID-19 Diagnostics Evidence Accelerator Parallel Analysis Workgroup

Related Assessment(s)
FDA Sentinel System's Coronavirus (COVID-19) Activities
Descriptive Assessment of the Natural History of Coagulopathy in COVID-19
Sentinel COVID-19 Evidence Accelerator Series
Presenter(s)

Mayura Shinde